Tokyo, Japan

Toshiya Ishii

This inventor holds 31 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Nec Corporation, Nec Lcd Technologies, Ltd., Toppan Printing Co., Ltd.. Active years: 2000-2022.

USPTO Granted Patents = 31 

% Patents Active = 80.6

 

Average Co-Inventor Count = 2.9

ph-index = 11

Forward Citations = 361(Granted Patents)


Location History:

  • Toyko, JP (2007)
  • Kanagawa, JP (2005 - 2011)
  • Tokyo, JP (2000 - 2022)

Company Filing History:


Years Active: 2000-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Liquid Crystal Display
Gas Barrier Laminate
Reflection Liquid Crystal Display
Ferroelectric Liquid Crystal Display
Active-Matrix Liquid Crystal Display
Orientation Division Type Liquid Crystal Display
Multi-Domain Liquid Crystal Display
Laminate Production
Cholesteric Color Filters
Manufacturing Methods
Driving Methods
Display Technology
31 patents (USPTO):Explore Patents

Title: Toshiya Ishii - Innovative Inventor from Tokyo

Introduction: Toshiya Ishii is a renowned inventor based in Tokyo, Japan, known for his groundbreaking contributions to various technological fields.

Latest Patents: Toshiya Ishii holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his diverse range of expertise.

Career Highlights: With over two decades of experience in the industry, Toshiya Ishii has worked with leading research institutions and universities to develop cutting-edge solutions that have revolutionized the way we approach modern challenges.

Collaborations: Throughout his career, Toshiya Ishii has collaborated with top companies in Japan and internationally, fostering innovation and driving progress in the global tech landscape.

Conclusion: Toshiya Ishii's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…